Ejaj K. Pathan

Ejaj K. Pathan

Auto-generated profile, based on publicly available information

Ejaj K. Pathan

Symbiosis School of Biological Sciences, Symbiosis International (Deemed University), Pune, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

23 January 2025 in Frontiers in Bioscience-Elite
Verified
Journal Article
Open access
PDF file
HSHimal Sapkota
Himal Sapkota
SDSubrata Dasgupta
Subrata Dasgupta
BRBishnudeo Roy
Bishnudeo Roy
EPEjaj K. Pathan
Ejaj K. Pathan
Cancer is a common, deadly disease with an unknown etiology. Meanwhile, current therapeutic options possess significant risks. However, probiotic bacteria and their metabolites have been reported to have antiproliferative and apoptotic effects on cancer cells. Therefore, because of their selective specificity and lack of treatment-associated comorbidities, these bacteria and their metabolites could be potential alternatives to conventional chemical and radiation therapies. Given their superior immunomodulatory and anti-cancer effects and lack of side effects, commensal bacteria derived from healthy humans are currently used as next-generation probiotics. This review summarizes current findings on these probiotic properties and anti-cancer activities of healthy human commensal bacteria. Additionally, the review focuses on small metabolites, proteins, and enzymes secreted by human commensal bacteria for their therapeutic applications against cancer. Further, utilizing a protein engineering strategy to reduce the toxicity of L-asparaginase, an enzyme-based anti-leukemia drug used for the last forty years, is also discussed. A possible workflow outline for isolating, identifying, screening, and characterizing human commensal bacterial strains for their therapeutic applications in cancer treatment is also proposed. This review emphasizes the need to explore various human commensal bacteria, not just mainstream lactic acid bacteria, for novel cancer therapeutics that provide multiple health benefits.

21 April 2025 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
SGSimran S. Ghogare
Simran S. Ghogare
EPEjaj K. Pathan
Ejaj K. Pathan
Cancer, uncontrolled cell growth due to the loss of cell cycle regulation, is often found to be associated with viral infections and, as recent studies show, with bacterial infections as well. Emerging reports also suggest a strong link between fungi and cancer. The crucial virulence trait of fungi, the switch from yeast (Y) to hyphal (H) form, is found to be associated with carcinogenesis. The physicochemical properties and signal transduction pathways involved in the switch to the hyphal form overlap with those of tumor cell formation. Inhibiting differentiation causes apoptosis in fungi, whereas preventing apoptosis leads to cancer in multicellular organisms. Literature on the fungi-cancer linkage, though limited, is increasing rapidly. This review examines cancer-specific fungal communities, the impact of fungal microbiome on cancer cell progression, similarities between fungal differentiation and cells turning cancerous at biochemical and molecular levels, including the overlaps in signal transduction pathways between fungi and cancer. Based on the available evidence, we suggest that molecules inhibiting the yeast-hyphal transition in fungi can be combined with those targeting tumor cell apoptosis for effective cancer treatment. The review points out fertile research areas where mycologists and cancer researchers can collaborate to unravel common molecular mechanisms. Moreover, antibodies targeting fungal-specific chitin and glucan can be used for the selective neutralization of tumor cells. These new combinations of potential therapies are expected to facilitate the development of target-specific, less harmful and commercially feasible anticancer therapies.

2 December 2024 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
CBCharvi D. Bandbe
Charvi D. Bandbe
KPKaran S. Patil
Karan S. Patil
EPEjaj K. Pathan
Ejaj K. Pathan

2 April 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
NRNamrata Raghavan
Namrata Raghavan
EPEjaj K. Pathan
Ejaj K. Pathan

7 June 2025 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
ASAkash Siotey
Akash Siotey
PJPurnima Jain
Purnima Jain
USUnnati Singhania
Unnati Singhania
EPEjaj K. Pathan
Ejaj K. Pathan
SSSwapnil L. Sonawane
Swapnil L. Sonawane